ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Karolinska Institutet at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Karolinska Institutet takes part in 17 sessions at ESMO 2026 in Madrid. Its program centres on cancer biomarkers and treatment across breast, prostate and other cancers. Specific topics include using circulating tumour DNA to guide treatment choices in metastatic prostate cancer and assessing artificial intelligence tools for breast cancer risk and screening.
| Organization | ESMO 2026 Attendance |
|---|---|
Karolinska Institutet Stockholm, Sweden | |
Medical university and research institute in Stockholm, Sweden, with a focus on medicine and health sciences. | Poster Fri Oct 23 13:00–15:00 Baseline patient characteristics according to ctDNA detectability in ProBio: A ctDNA-driven platform trial for metastatic hormone-sensitive prostate cancer Genitourinary cancersBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Real-world biomarker testing and treatment patterns in unresectable or metastatic gastric and gastroesophageal junction cancer: A Swedish single-centre cohort study of 345 patients Gastrointestinal cancersBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Transcriptomic relative immune-stromal balance in ER-positive/HER2-positive breast cancer Breast cancerBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Deciphering the immune landscape of intrahepatic cholangiocarcinoma in relation to prognosis Gastrointestinal cancersSarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 15:15–16:00 Large-scale real-world evidence from ctDNA testing in Sweden in metastatic castration-resistant prostate cancer (mCRPC) to identify BRCA alterations Genitourinary cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Upfront genetic sequencing in stage I–III colorectal cancer: The ALASCCA screening cohort Gastrointestinal cancersBiomarkers & precision oncology Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Mon Oct 26 12:00–12:45 EXILENS: Real-world treatment outcomes in EGFR exon 20 insertion-mutated non-small cell lung cancer — A nationwide Swedish cohort Lung & thoracic cancersSarcoma, CNS, head & neck and rare cancers Poster Mon Oct 26 12:00–12:45 |
Find decision makers at Karolinska Institutet
Tell us what you sell and we’ll find the people at Karolinska Institutet most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction